首页> 外文期刊>Biological & pharmaceutical bulletin >Neutralization of Acidic Tumor Microenvironment (TME) with Daily Oral Dosing of Sodium Potassium Citrate (K/Na Citrate) Increases Therapeutic Effect of Anti-cancer Agent in Pancreatic Cancer Xenograft Mice Model
【24h】

Neutralization of Acidic Tumor Microenvironment (TME) with Daily Oral Dosing of Sodium Potassium Citrate (K/Na Citrate) Increases Therapeutic Effect of Anti-cancer Agent in Pancreatic Cancer Xenograft Mice Model

机译:用每日口服柠檬酸钠(K / Na柠檬酸钠)的酸性肿瘤微环境(TME)的中和增加(K / Na柠檬酸盐)增加抗癌剂在胰腺癌异种移植小鼠模型中的治疗效果

获取原文
获取原文并翻译 | 示例
           

摘要

Extracellular pH (pHe) of tumor cells is characteristic of tumor microenvironment (TME). Acidic TME impairs the responses of tumors to some anti-cancer chemotherapies. In this study, we showed that daily oral dosing of sodium potassium citrate (K/Na citrate) increased blood HCO3- concentrations, corresponding to increase of HCO3- concentrations and pHs in urine, and neutralized the tumor pHe. Neutralization of acidic TME by alkaline substance like HCO3-, an active metabolite of K/Na citrate, well potentiated the therapeutic effect of anticancer agent TS-1 (R), an orally active 5-fuluoro-uracil derivative, in Panc-1 pancreatic cancer-xenograft murine model. Neutralization of acidic TME by using an alkaline K/Na citrate is a smart approach for enhancement of the therapeutic effects of anticancer agents for pancreatic cancer in the end stage.
机译:肿瘤细胞的细胞外pH(pHE)是肿瘤微环境(TME)的特征。 酸性TME损害肿瘤对一些抗癌化疗的反应。 在这项研究中,我们表明,柠檬酸钠(K / Na柠檬酸盐)的日常口服给药增加了血液HCO3-浓度,对应于HCO3-浓度和尿液中的pH,并中和肿瘤pHE。 用HCO3-碱性物质的酸性TME中和,K / Na柠檬酸盐的活性代谢物,抗癌剂TS-1(R)的治疗作用,Panc-1胰腺(Panc-1) 癌症异种移植鼠模型。 使用碱性K / Na柠檬酸盐中和酸性TME是一种智能方法,用于提高抗癌剂在最终阶段胰腺癌的治疗效果。

著录项

相似文献

  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号